Bangalore: Greenspace Herbs has announced the launch of its Quantum Ayurveda platform in the United States, aiming to bring clinically validated, technology-enhanced botanical supplements to one of the world’s largest wellness markets.
The initiative combines traditional Ayurvedic botanicals with frequency-based technological enhancement to improve ingredient absorption and effectiveness. The company says the platform has been supported by published clinical studies showing that enhanced botanicals such as curcumin, ashwagandha, bacopa and berberine can deliver measurable results at significantly lower doses than conventional supplements.
Already introduced across India and several Asian markets, the platform is now being expanded into the U.S. dietary supplement market, which is estimated to be valued at over $50 billion. To support its American operations, the company has established a warehouse and operational base in New Jersey.

Explaining the vision behind the platform, Shafiulla Hirehal Nuruddin, Founder and Managing Director of Greenspace Herbs, said, “Today’s wellness consumer is educated, demanding, and done with empty promises. They want to know: what does the science say, and will I feel the difference? Quantum Ayurveda was built specifically to answer both questions. We have done the clinical work. We have published the results. Now we are here in the U.S. to ensure that every consumer who chooses our platform experiences wellness that is real, measurable, and rooted in thousands of years of botanical knowledge — elevated by 21st-century science.”
To lead its expansion in the U.S., Greenspace Herbs has appointed Gregory Arabatzis as Chief Business Officer – USA. A veteran of the nutraceutical industry with over two decades of experience, Arabatzis is expected to oversee commercialisation efforts, partnerships, and market development.
Commenting on the opportunity, Gregory Arabatzis, Chief Business Officer – USA, Greenspace Herbs, said, “The U.S. market rewards clinically substantiated innovation. Quantum Ayurveda stands out because it is not theoretical — it is supported by published scientific data. Our focus now is structured commercialisation, education, and partnership development.”
The company says its technology improves the bioavailability of botanical ingredients, allowing supplements to work effectively at nearly one-third of traditional dosage levels, potentially reducing the need for high-dose formulations while delivering faster cellular response.
Looking ahead, Greenspace Herbs also plans to establish Quantum Technology Frequency Labs in the United States, which will focus on clinical collaborations, ingredient customisation and co-development programs with partners.
With the U.S. launch, the company aims to position its Quantum Ayurveda platform as a science-backed alternative in a crowded supplement market, offering consumers botanicals rooted in traditional Ayurvedic knowledge but enhanced through modern scientific innovation.
















